Cargando…
New developments in the management of congenital Factor XIII deficiency
Congenital Factor XIII (FXIII) deficiency is a rare, inherited, autosomal recessive coagulation disorder. Most mutations of this condition are found in the A-subunit with almost half these being missense mutations. Globally, approximately one in three million people suffer from this deficiency. Fact...
Autores principales: | Fadoo, Zehra, Merchant, Quratulain, Rehman, Karim Abdur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674014/ https://www.ncbi.nlm.nih.gov/pubmed/23761984 http://dx.doi.org/10.2147/JBM.S32693 |
Ejemplares similares
-
New developments in the management of congenital Factor XIII deficiency [Corrigendum]
Publicado: (2013) -
How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency
por: Shahraki, Hojat, et al.
Publicado: (2020) -
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
por: Korte, Wolfgang
Publicado: (2014) -
Current understanding in diagnosis and management of factor XIII deficiency
por: Naderi, M, et al.
Publicado: (2013) -
Safety and effectiveness of recombinant factor XIII‐A(2) in congenital factor XIII deficiency: Real‐world evidence
por: Poulsen, Lone Hvitfeldt, et al.
Publicado: (2022)